134 related articles for article (PubMed ID: 1720700)
1. Inhibitory effect of granulocyte-macrophage colony-stimulating factor therapy on the generation of natural killer cells.
Shibuya A; Taguchi K; Kojima H; Abe T
Blood; 1991 Dec; 78(12):3241-7. PubMed ID: 1720700
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effect of granulocyte-macrophage colony-stimulating factor on the generation of natural killer cells in vitro.
Taguchi K; Shibuya A; Inazawa Y; Abe T
Blood; 1992 Jun; 79(12):3227-32. PubMed ID: 1375846
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of recombinant human granulocyte-macrophage colony-stimulating factor in myelodysplastic syndrome and aplastic anemia.
Takahashi M; Yoshida Y; Kaku K; Masaoka T; Moriyama Y; Nakanishi S; Kaneko T; Shibata A; Miwa S
Acta Haematol; 1993; 89(4):189-94. PubMed ID: 8212999
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human granulocyte macrophage-colony stimulating factor in long-term marrow cultures from patients with aplastic anemia.
Martínez-Jaramillo G; Gómez-Morales E; Mayani H
Am J Hematol; 1999 Jun; 61(2):107-14. PubMed ID: 10367789
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
Nagler A; Ginzton N; Negrin R; Bang D; Donlon T; Greenberg P
Leukemia; 1990 Mar; 4(3):193-202. PubMed ID: 1690318
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony-stimulating factors.
Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
[No Abstract] [Full Text] [Related]
7. Recombinant human granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes.
Hansen PB; Johnsen HE; Hippe E; Hellström-Lindberg E; Ralfkiaer E
Am J Hematol; 1993 Dec; 44(4):229-36. PubMed ID: 8237992
[TBL] [Abstract][Full Text] [Related]
8. Southwestern Internal Medicine Conference: clinical use of hematopoietic growth factors.
Fleischman RA
Am J Med Sci; 1993 Apr; 305(4):248-73. PubMed ID: 7682752
[TBL] [Abstract][Full Text] [Related]
9. [Advances in the research of clinical use of recombinant human granulocyte colony-stimulating factors].
Jiang FG; Geng JP; Yang CL
Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):723-5. PubMed ID: 1726145
[No Abstract] [Full Text] [Related]
10. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
Peters WP; Rosner G; Ross M; Vredenburgh J; Meisenberg B; Gilbert C; Kurtzberg J
Blood; 1993 Apr; 81(7):1709-19. PubMed ID: 7681699
[TBL] [Abstract][Full Text] [Related]
11. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial.
Ganser A; Völkers B; Greher J; Ottmann OG; Walther F; Becher R; Bergmann L; Schulz G; Hoelzer D
Blood; 1989 Jan; 73(1):31-7. PubMed ID: 2642714
[TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant human granulocyte-macrophage colony-stimulating factor administration on the lymphocyte subsets of patients with refractory aplastic anemia.
Faisal M; Cumberland W; Champlin R; Fahey JL
Blood; 1990 Oct; 76(8):1580-5. PubMed ID: 2207331
[TBL] [Abstract][Full Text] [Related]
14. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial.
Lazarus HM; Andersen J; Chen MG; Variakojis D; Mansour EG; Oette D; Arce CA; Oken MM; Gerson SL
Blood; 1991 Aug; 78(3):830-7. PubMed ID: 1859894
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow.
Orazi A; Cattoretti G; Schiró R; Siena S; Bregni M; Di Nicola M; Gianni AM
Blood; 1992 May; 79(10):2610-9. PubMed ID: 1586713
[TBL] [Abstract][Full Text] [Related]
16. Impact of marrow cytogenetics and morphology on in vitro hematopoiesis in the myelodysplastic syndromes: comparison between recombinant human granulocyte colony-stimulating factor (CSF) and granulocyte-monocyte CSF.
Nagler A; Binet C; Mackichan ML; Negrin R; Bangs C; Donlon T; Greenberg P
Blood; 1990 Oct; 76(7):1299-307. PubMed ID: 1698477
[TBL] [Abstract][Full Text] [Related]
17. Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Ohta M; Miura Y; Takaku F; Saito M
Exp Hematol; 1992 Oct; 20(9):1090-3. PubMed ID: 1281785
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic growth factors for the treatment of myelodysplastic syndromes.
Hansen PB; Penkowa M; Johnsen HE
Leuk Lymphoma; 1998 Feb; 28(5-6):491-500. PubMed ID: 9613978
[TBL] [Abstract][Full Text] [Related]
19. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
[TBL] [Abstract][Full Text] [Related]
20. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]